Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-23

Clinical Trial Update: Lycopene or Green Tea for Men at Risk of Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on lycopene or green tea for men at risk of prostate cancer; completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Bristol | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED